news
NHS releases guidance to remove drugs from prescription list
Seven medications have been suggested for removal from prescriptions by the NHS after a public consultation.
List view / Grid view
Drug Markets
news
Gastrointestinal drugs market set to reach $61.6 billion by 2024
The rise of diseases such as inflammatory bowel syndrome is projected to drive the global gastrointestinal drugs market in the upcoming years.
news
EU releases guidance for medicine shortages
The EU has issued two guidance documents intended to advise the pharmaceutical industry and patients during medicinal shortages.
news
NICE endorses dacomitinib for treatment of lung cancer
Vizimpro (dacomitinib) has been recommended as a first-line treatment option for patients with lung cancer.
news
US government takes steps to reduce drug costs
New regulations and legislations are being formed in the US to combat healthcare costs, including drug prices.
news
£3 million for no-deal Brexit medication transport
The DHSC has announced their plans for pharmaceutical transportation in the case of a no-deal Brexit.
news
Decision by NICE for the use of osimertinib to be appealed
A pharmaceutical company will appeal a decision by NICE to not recommend osimertinib for use within NHS England.
news
FDA approves treatment for refractory multiple myeloma
Accelerated approval has been granted to Xpovio to treat refractory multiple myeloma by the FDA.
news
Phase III programme for the use of otilimab for rheumatoid arthritis launched
A Phase III clinical development programme testing otilimab in patients with RA has begun.
news
Global pharmaceutical filler market set to increase 5.7 percent
The filler market is predicted to increase to US$2 billion by 2024, according to a new report.
news
New analysis shows that 3,400 drug prices have risen in 2019 so far
The price of over 3400 drugs have been hiked in the first half of 2019, surpassing the number of hikes imposed during the same period last year.
article
The impact of counterfeit drugs in south and south-east Asia
Substandard and counterfeit drugs can negatively impact the pharmaceutical industry and patients. Here, we investigate counterfeits in south-east Asia and possible solutions.
news
Trump administration sees FDA enforcement actions decline
A study has shown the warning letters the FDA distributes have decreased by a third since Trump came to office.
news
Macleods Pharmaceuticals issues recall due to NMBA impurities
Macleods has issued a recall of 32 lots of drug products that contained trace amounts of NMBA impurities.
news
Jet-lag medication approved by MHRA
The MHRA has given marketing authorisation for short-term jet-lag therapy in adults.
